Topic
OssaTron
About: OssaTron is a research topic. Over the lifetime, 7 publications have been published within this topic receiving 298 citations.
Papers
TL;DR: The current study showed that the directed application of electrohydraulic-generated shock waves to the insertion of the plantar fascia onto the calcaneus is a safe and effective nonsurgical method for treating chronic, recalcitrant heel pain syndrome.
Abstract: Three hundred two patients with chronic heel pain caused by proximal plantar fasciitis were enrolled in a study to assess the treatment effects consequent to administration of electrohydraulicall-generated extracorporeal shock waves. Symptoms had been present from 6 months to 18 years. Each treated patient satisfied numerous inclusion and exclusion criteria before he or she was accepted into this study, which was approved by the Food and Drug Administration as a randomized, double-blind evaluation of the efficacy of shock wave therapy for this disorder. Overall, at the predetermined evaluation period 3 months after one treatment, 56% more of the treated patients had a successful result by all four of the evaluation criteria when compared with the patients treated with a placebo. This difference was significant and corroborated the fact that this difference in the results was specifically attributable to the shock wave treatment, rather than any natural improvement caused by the natural history of the condition. The current study showed that the directed application of electrohydraulic-generated shock waves to the insertion of the plantar fascia onto the calcaneus is a safe and effective nonsurgical method for treating chronic, recalcitrant heel pain syndrome that has been present for at least 6 months and has been refractory to other commonly used nonoperative therapies. This technology, when delivered using the OssaTron (High Medical Technology, Kreuz-lingen, Switzerland), has been approved by the Food and Drug Administration specifically for the treatment of chronic proximal plantar fasciitis. The results suggest that this therapeutic modality should be considered before any surgical options, and even may be preferable to cortisone injection, which has a recognized risk of rupture of the plantar fascia and recurrence of symptoms.
241 citations
TL;DR: It is concluded that orthotripsy is a safe and effective method of treating heel pain syndrome that has been unresponsive to nonoperative management.
Abstract: The OssaTron may be another alternative for management of plantar fasciitis (heel pain syndrome) after failure of non-operative management and prior to surgical management. This study evaluated primarily the safety and early preliminary efficacy of the OssaTron in treatment of patients with plantar fasciitis unresponsive to non-operative management. Twenty heels of 20 patients were treated with 1000 extracorporeal shockwaves from the OssaTron to the affected heel after administration of a heel block. The patients were followed for one year. Each patient was evaluated by roentgenogram, KinCom, range of motion and physical examination, including evaluation of point tenderness by means of a palpometer and according to a 10-cm visual analog scale. The control was the contralateral heel. Patients also performed self evaluation by means of patient activities of daily living questionnaire and pain reported by a 10-cm visual analog scale. There were no complications or adverse effects attributed to the procedure of orthotripsy. Of the 20 patients treated, 18 were improved or pain-free. Eighteen of the 20 subjects treated stated that they would undergo the procedure again instead of surgery. Based on these results, we concluded that orthotripsy is a safe and effective method of treating heel pain syndrome that has been unresponsive to nonoperative management.
28 citations
TL;DR: The focus of this article is treatment of chronic proximal plantar fasciitis; however, other pathologies of the lower extremity demonstrate great promise for this emerging technology.
26 citations
TL;DR: The results of this study corroborate the value of ESWT for recalcitrant plantar fascitis as a non invasive technique with low side effects, it can complement the row of conservative treatments.
Abstract: Aim Efficacy of low-energy shock wave therapy for recalcitrant plantar fasciitis. Method 32 patients were randomly assigned into real and placebo ESWT groups, treatment comprised 1000 impulses of 0,08 mJ/mm 2 at 14 kV (OssaTron OSA 120, HMT AG, Switzerland) in 12 cases repeated after six weeks or placebo (energy-absorbing foil). Follow-up evaluation (19, 32 and 48 wks.) included specific questionnaire, clinical-functional examination and measurement of plantar pressure while walking (Emed AT-4. pedograph, Novel GmbH, Munich). Examiner and patients were blinded. Results 88 % of the treatment group were pain free or had good results. None of the placebo group were pain free, 33.3 % had good results (Roles and Maudsley Score). The treatment group showed significantly better outcome for morning and resting pain, pressure stamp-tolerance and walking ability. Pedography did not show a clear correlation between pain relief and load pattern. Conclusion The results of this study corroborate the value of ESWT for recalcitrant plantar fascitis. As a non invasive technique with low side effects, it can complement the row of conservative treatments.
22 citations
TL;DR: The results of a meta-analysis by Odgen et al demonstrated that, of various applications of ESWT on musculoskeletal conditions, the use of ES WT for treating plantar fasciitis was the most credible.
Abstract: Extracorporeal shock wave therapy (ESWT) is an emerging treatment modality for managing pain caused by various musculoskeletal disorders. According to recent systematic reviews by Crawford et al and Odgen et al, evidence is accumulating to support the use of ESWT as an effective treatment for heel pain. The US Food and Drug Administration has, in fact, approved the use of the electrohydraulic OssaTron (High Medical Technology, Kreuzlingen, Switzerland) for the treatment of plantar fasciitis. The results of a meta-analysis by Odgen et al demonstrated that, of various applications of ESWT on musculoskeletal conditions, the use of ESWT for treating plantar fasciitis was the most credible. As ESWT may become a new and popular treatment for managing heel pain and possibly other musculoskeletal disorders, the purpose of this paper is to review the background knowledge of ESWT and to describe the technical details of this new modality in treating heel pain. J Orthop Sports Phys Ther. 2003; 33(6):337–343.
17 citations
Related Topics (5)
Performance Metrics
| Year | Papers |
|---|---|
| 2008 | 1 |
| 2007 | 1 |
| 2004 | 1 |
| 2003 | 1 |
| 2002 | 2 |
| 2001 | 1 |